Discovery of novel 2-aryl-4-bis-amide imidazoles (ABAI) as anti-inflammatory agents for the treatment of inflammatory bowel diseases (IBD)
Ling Li(Southern Medical University), Sijie Yuan(Nanfang Hospital), Peihua Kuang(Nanfang Hospital), Jingxuan Chen(Guangdong Pharmaceutical University), Lin Lin(Southern Medical University), Jianjun Chen(Gannan Medical University), Ting Chen(Tianjin Medical University), Ting Liu(Central South University), Fang Yang(Southern Medical University), Wenzhen Liao(Southern Medical University), Chenglong Xu(Southern Medical University), Huiting Zhao(Shandong University of Technology)
Cited by 12
Related Papers
Novel CRBN-Recruiting Proteolysis-Targeting Chimeras as Degraders of Stimulator of Interferon Genes with In Vivo Anti-Inflammatory Efficacy
|Journal of Medicinal Chemistry|2022|94
LncRNA Airn maintains LSEC differentiation to alleviate liver fibrosis via the KLF2-eNOS-sGC pathway
|BMC Medicine|2022|59
Discovery of KRas G12C-IN-3 and Pomalidomide-based PROTACs as degraders of endogenous KRAS G12C with potent anticancer activity
|Bioorganic Chemistry|2021|40
Biosynthetic molecular imaging probe for tumor-targeted dual-modal fluorescence/magnetic resonance imaging
|Biomaterials|2020|39
Interplay of PKD3 with SREBP1 Promotes Cell Growth via Upregulating Lipogenesis in Prostate Cancer Cells
|Journal of Cancer|2019|31